NYSE:TFX - Teleflex Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $462.90
  • Forecasted Upside: 15.64 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 9 Buy Ratings
  • 1 Strong Buy Ratings
▲ +3.42 (0.86%)

This chart shows the closing price for TFX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Teleflex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TFX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TFX

Analyst Price Target is $462.90
▲ +15.64% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Teleflex in the last 3 months. The average price target is $462.90, with a high forecast of $485.00 and a low forecast of $440.00. The average price target represents a 15.64% upside from the last price of $400.29.

This chart shows the closing price for TFX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 polled investment analysts is to buy stock in Teleflex. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 1 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/2/2021Jefferies Financial GroupReiterated RatingBuy$485.00Medium
5/23/2021SVB LeerinkReiterated RatingBuyLow
4/30/2021Morgan StanleyBoost Price TargetOverweight$450.00 ➝ $478.00Medium
4/30/2021SVB LeerinkBoost Price TargetOutperform$475.00 ➝ $485.00Medium
3/12/2021Raymond JamesBoost Price TargetStrong-Buy$460.00 ➝ $480.00Medium
2/26/2021Raymond JamesBoost Price TargetStrong-Buy$440.00 ➝ $460.00Low
2/25/2021Piper SandlerReiterated RatingOverweight$405.00 ➝ $465.00Medium
1/27/2021JMP SecuritiesBoost Price TargetMarket Outperform$375.00 ➝ $440.00Low
1/11/2021Wells Fargo & CompanyBoost Price TargetOverweight$425.00 ➝ $455.00Medium
1/8/2021KeyCorpBoost Price TargetOverweight$382.00 ➝ $441.00Medium
1/6/2021Needham & Company LLCBoost Price TargetBuy$406.00 ➝ $445.00N/A
12/15/2020Morgan StanleyBoost Price TargetOverweight$375.00 ➝ $450.00Low
12/15/2020UBS GroupBoost Price TargetBuy$435.00 ➝ $455.00High
12/15/2020SVB LeerinkBoost Price TargetOutperform$415.00 ➝ $450.00High
12/3/2020Raymond JamesBoost Price TargetStrong-Buy$400.00 ➝ $440.00Low
11/2/2020KeyCorpUpgradeSector Weight ➝ Overweight$382.00Low
10/30/2020Piper SandlerLower Price Target$420.00 ➝ $405.00High
10/30/2020Morgan StanleyLower Price TargetOverweight$400.00 ➝ $375.00Medium
10/30/2020Raymond JamesLower Price TargetStrong-Buy$440.00 ➝ $400.00High
10/30/2020SVB LeerinkLower Price TargetOutperform$430.00 ➝ $415.00High
8/28/2020Raymond JamesReiterated RatingBuyMedium
7/31/2020Raymond JamesBoost Price TargetStrong-Buy$400.00 ➝ $440.00Low
7/31/2020Morgan StanleyBoost Price TargetOverweight$380.00 ➝ $400.00Medium
6/4/2020SVB LeerinkBoost Price TargetTop Pick ➝ Outperform$400.00 ➝ $425.00Low
5/1/2020UBS GroupLower Price TargetBuy$440.00 ➝ $410.00High
5/1/2020JMP SecuritiesLower Price TargetMarket Outperform$395.00 ➝ $385.00Medium
5/1/2020Wells Fargo & CompanyBoost Price TargetOverweight$365.00 ➝ $375.00High
5/1/2020Morgan StanleyBoost Price TargetOverweight$350.00 ➝ $380.00Medium
5/1/2020Raymond JamesBoost Price TargetStrong-Buy$360.00 ➝ $400.00Medium
5/1/2020Piper SandlerLower Price TargetOverweight$425.00 ➝ $375.00Medium
4/30/2020Needham & Company LLCReiterated RatingBuy$431.00Medium
4/3/2020Raymond JamesLower Price TargetStrong-Buy$450.00 ➝ $360.00Low
3/27/2020Morgan StanleyLower Price TargetOverweight$405.00 ➝ $350.00Medium
3/23/2020StephensLower Price TargetOverweight$425.00 ➝ $275.00High
2/24/2020BarclaysReiterated RatingHold$365.00 ➝ $378.00Medium
2/21/2020Piper SandlerBoost Price Target$425.00 ➝ $400.00Low
2/21/2020StephensBoost Price TargetOverweight$400.00 ➝ $425.00High
2/21/2020Raymond JamesBoost Price TargetStrong-Buy$415.00 ➝ $450.00High
2/21/2020UBS GroupBoost Price TargetBuy$430.00 ➝ $440.00High
1/31/2020Needham & Company LLCBoost Price TargetBuy$408.00 ➝ $423.00High
1/17/2020Wells Fargo & CompanyBoost Price TargetOverweight$415.00 ➝ $425.00Low
12/18/2019UBS GroupBoost Price TargetBuy$415.00 ➝ $430.00Medium
12/17/2019Morgan StanleyBoost Price TargetOverweight$392.00 ➝ $405.00Low
11/1/2019BarclaysSet Price TargetHold$356.00 ➝ $365.00N/A
10/15/2019Needham & Company LLCSet Price TargetBuy$403.00Low
10/7/2019Raymond JamesLower Price TargetStrong-Buy$420.00 ➝ $415.00Low
9/4/2019SVB LeerinkBoost Price TargetOutperform$395.00 ➝ $405.00Medium
8/5/2019BarclaysBoost Price TargetEqual Weight$309.00 ➝ $356.00Low
8/5/2019JMP SecuritiesBoost Price TargetMarket Outperform$325.00 ➝ $395.00Medium
8/2/2019Raymond JamesBoost Price TargetStrong-Buy$350.00 ➝ $420.00Low
8/2/2019Morgan StanleyBoost Price TargetOverweight$345.00 ➝ $392.00Low
8/2/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$325.00 ➝ $403.00Low
7/16/2019Morgan StanleyBoost Price TargetOverweight$320.00 ➝ $345.00Low
6/11/2019Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$345.00Low
4/24/2019Needham & Company LLCDowngradeStrong-Buy ➝ Buy$325.00Low
4/15/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$287.00 ➝ $309.00Low
3/27/2019Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$320.00 ➝ $348.00Medium
3/26/2019Needham & Company LLCReiterated RatingBuy$325.00Medium
3/22/2019UBS GroupBoost Price TargetBuy$350.00Low
2/26/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$305.00 ➝ $315.00Low
2/22/2019BarclaysSet Price TargetHold$287.00Medium
2/22/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$300.00 ➝ $325.00High
1/2/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$295.00 ➝ $305.00Medium
11/27/2018UBS GroupInitiated CoverageBuy$310.00High
11/2/2018Piper Jaffray CompaniesBoost Price TargetOverweight$310.00Medium
11/2/2018Needham & Company LLCReiterated RatingBuy$315.00High
10/15/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$266.00Low
9/10/2018Needham & Company LLCUpgradeBuy ➝ Strong-Buy$279.00 ➝ $300.00High
8/3/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$310.00 ➝ $295.00Medium
8/3/2018Needham & Company LLCLower Price TargetBuy$298.00 ➝ $279.00Medium
6/5/2018SVB LeerinkBoost Price TargetOutperform$309.00 ➝ $317.00Medium
5/15/2018Needham & Company LLCBoost Price TargetBuy$293.00 ➝ $298.00Medium
5/9/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$293.00 ➝ $298.00Low
5/4/2018Deutsche Bank AktiengesellschaftSet Price TargetHold ➝ Hold$251.00 ➝ $255.00Low
5/3/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$285.00 ➝ $293.00Medium
4/4/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$257.00Low
2/23/2018SVB LeerinkLower Price TargetOutperform ➝ Outperform$321.00 ➝ $300.00High
1/30/2018SVB LeerinkReiterated RatingBuy$307.00 ➝ $321.00High
1/18/2018StephensReiterated RatingBuy$300.00High
11/14/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$251.00N/A
11/10/2017Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$295.00N/A
11/3/2017Morgan StanleyBoost Price TargetEqual Weight$274.00 ➝ $290.00N/A
11/3/2017Jefferies Financial GroupBoost Price TargetBuy$270.00 ➝ $295.00N/A
11/3/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$237.00 ➝ $285.00N/A
9/25/2017StephensReiterated RatingBuy$230.00 ➝ $270.00Low
9/18/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$238.00 ➝ $251.00Low
9/12/2017BarclaysReiterated RatingOverweight$230.00 ➝ $253.00Low
9/8/2017Jefferies Financial GroupBoost Price TargetBuy$253.00 ➝ $270.00High
9/7/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$227.00 ➝ $266.00High
9/6/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$220.00 ➝ $274.00Low
9/6/2017KeyCorpReiterated RatingHoldHigh
9/5/2017Needham & Company LLCBoost Price TargetBuy$228.00 ➝ $237.00Low
8/9/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$220.00 ➝ $238.00Low
8/9/2017Jefferies Financial GroupReiterated RatingBuy$230.00 ➝ $253.00Low
8/4/2017Needham & Company LLCReiterated RatingBuyMedium
8/3/2017Jefferies Financial GroupReiterated RatingBuy$230.00High
6/26/2017BarclaysReiterated RatingBuyLow
6/9/2017SVB LeerinkBoost Price TargetMarket Perform$215.00 ➝ $220.00Low
5/8/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$213.00 ➝ $220.00Low
5/5/2017Needham & Company LLCReiterated RatingBuy$224.00Medium
3/27/2017Jefferies Financial GroupReiterated RatingHoldLow
3/25/2017Jefferies Financial GroupSet Price TargetBuy$205.00Low
3/15/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$192.00 ➝ $213.00Medium
3/6/2017Needham & Company LLCInitiated CoverageBuy$221.00N/A
3/1/2017BarclaysReiterated RatingBuy$205.00N/A
2/24/2017StephensUpgradeEqual Weight ➝ OverweightN/A
2/13/2017SVB LeerinkBoost Price TargetMarket Perform$151.00 ➝ $177.00N/A
1/6/2017Jefferies Financial GroupUpgradeHold ➝ Buy$155.00 ➝ $190.00N/A
12/6/2016Jefferies Financial GroupReiterated RatingHold$154.00 ➝ $155.00N/A
10/28/2016StephensDowngradeOverweight ➝ Equal WeightN/A
7/29/2016Jefferies Financial GroupBoost Price TargetHold$157.00 ➝ $185.00N/A
7/29/2016BarclaysBoost Price TargetOverweight$183.00 ➝ $185.00N/A
7/29/2016SVB LeerinkBoost Price TargetMarket Perform$183.00 ➝ $190.00N/A
(Data available from 6/21/2016 forward)
Teleflex logo
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Read More

Today's Range

Now: $400.29
Low: $392.13
High: $403.93

50 Day Range

MA: $409.17
Low: $385.96
High: $443.85

52 Week Range

Now: $400.29
Low: $312.33
High: $449.38


238,933 shs

Average Volume

211,214 shs

Market Capitalization

$18.71 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Teleflex?

The following Wall Street sell-side analysts have issued reports on Teleflex in the last twelve months: Jefferies Financial Group Inc., JMP Securities, KeyCorp, Morgan Stanley, Needham & Company LLC, Piper Sandler, Raymond James, SVB Leerink LLC, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for TFX.

What is the current price target for Teleflex?

10 Wall Street analysts have set twelve-month price targets for Teleflex in the last year. Their average twelve-month price target is $462.90, suggesting a possible upside of 16.6%. Jefferies Financial Group Inc. has the highest price target set, predicting TFX will reach $485.00 in the next twelve months. JMP Securities has the lowest price target set, forecasting a price of $440.00 for Teleflex in the next year.
View the latest price targets for TFX.

What is the current consensus analyst rating for Teleflex?

Teleflex currently has 9 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TFX will outperform the market and that investors should add to their positions of Teleflex.
View the latest ratings for TFX.

What other companies compete with Teleflex?

How do I contact Teleflex's investor relations team?

Teleflex's physical mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company's listed phone number is 610-225-6800 and its investor relations email address is [email protected] The official website for Teleflex is www.teleflex.com.